Almirall SA ALMIRALL ORD SHS | 12.53 / -0.71% |
Date/Time | 04/16 / 18:56 |
Chg. / Chg.(%) | -0.09 / -0.71% |
Bid | 12.27 / 5000 |
Ask | 12.79 / 5000 |
Open | 12.70 |
Previous Close | 12.62 |
High | 12.62 |
Low | 12.46 |
Volume [EUR] | 473,628.65 |
Volume [Units] | 44,474 |
Price fixings | 90 |
ISIN | ES0157097017 |
Security | 0O9B |
Exchange | London International |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 12.460 | ![]() |
|
Madrid | 12.5500 | ![]() |
236,965 |
Cboe Europe .. | 12.55 | ![]() |
49,249 |
London Inter.. | 12.53 | ![]() |
44,474 |
Turquoise | 12.54 | ![]() |
10,341 |
Cboe Europe .. | 12.50 | ![]() |
810 |
Cboe Europe .. | 12.50 | ![]() |
803 |
Frankfurt | 12.5700 | ![]() |
0 |
Berlin | 12.580 | ![]() |
0 |
Stuttgart | 12.470 | ![]() |
0 |
TradeGate | 12.41 | 640 | |
Nasdaq Other.. | 15.0000 | 1,000 |
News
- Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
04/01/2021 / 22:01 - GlobeNewswire - Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications
03/24/2021 / 12:00 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
03/01/2021 / 22:01 - GlobeNewswire - Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update
03/01/2021 / 13:05 - GlobeNewswire - Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million
02/24/2021 / 22:01 - GlobeNewswire